CellAct Pharma GmbH

Organization

Dortmund, DE

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Method for the diagnosis of etoposide prodrug treatable cancer
- Patent number 11,892,454
- Issue date Feb 6, 2024
- CellAct Pharma GmbH
- Nalan Utku
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Etoposide and prodrugs thereof for use in targeting cancer stem cells
- Patent number 10,183,035
- Issue date Jan 22, 2019
- CellAct Pharma GmbH
- Nalan Utku
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Analogues of etoposide for the treatment of tumours
- Patent number 9,889,147
- Issue date Feb 13, 2018
- CellAct Pharma GmbH
- Nalan Utku
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Etoposide and prodrugs thereof for use in targeting cancer stem cells
- Patent number 9,827,261
- Issue date Nov 28, 2017
- CellAct Pharma GmbH
- Nalan Utku
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptides capable of modulating the function of TIRC7
- Patent number 9,096,654
- Issue date Aug 4, 2015
- CellAct Pharma GmbH
- Nalân Utku
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of detecting early immune activation
- Patent number 8,642,512
- Issue date Feb 4, 2014
- CellAct Pharma GmbH
- Nalân Utku
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-TIRC7 antibodies in therapy of inflammatory diseases
- Patent number 7,794,715
- Issue date Sep 14, 2010
- CellAct Pharma GmbH
- Nalan Utku
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
ETOPOSIDE TONIRIBATE FORMULATION
- Publication number 20230398069
- Publication date Dec 14, 2023
- CellAct Pharma GmbH
- Davide GUGGI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR THE DIAGNOSIS OF ETOPOSIDE PRODRUG TREATABLE CANCER
- Publication number 20190086418
- Publication date Mar 21, 2019
- CellAct Pharma GmbH
- Nalan Utku
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANALOGUES OF ETOPOSIDE FOR THE TREATMENT OF TUMOURS
- Publication number 20180125873
- Publication date May 10, 2018
- CellAct Pharma GmbH
- Nalân Utku
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ETOPOSIDE AND PRODRUGS THEREOF FOR USE IN TARGETING CANCER STEM CELLS
- Publication number 20160022721
- Publication date Jan 28, 2016
- CellAct Pharma GmbH
- Nalan UTKU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PEPTIDES CAPABLE OF MODULATING THE FUNCTION OF TIRC7
- Publication number 20140154279
- Publication date Jun 5, 2014
- CellAct Pharma GmbH
- Nalân UTKU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Analogues of Etoposide for the Treatment of Tumours
- Publication number 20130130998
- Publication date May 23, 2013
- CellAct Pharma GmbH
- Nalân Utku
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL TARGET IN THE TREATMENT OF CYTOKINE RELEASE SYNDROME
- Publication number 20120282272
- Publication date Nov 8, 2012
- CellAct Pharma GmbH
- Nalân Utku
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL TARGET IN THE TREATMENT OF CYTOKINE RELEASE SYNDROME
- Publication number 20090175879
- Publication date Jul 9, 2009
- CellAct Pharma GmbH
- Nalân Utku
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

CellAct Pharma GmbH

Organization

Patents Grantslast 30 patents

Method for the diagnosis of etoposide prodrug treatable cancer

Etoposide and prodrugs thereof for use in targeting cancer stem cells

Analogues of etoposide for the treatment of tumours

Etoposide and prodrugs thereof for use in targeting cancer stem cells

Peptides capable of modulating the function of TIRC7

Method of detecting early immune activation

Anti-TIRC7 antibodies in therapy of inflammatory diseases

Patents Applicationslast 30 patents

ETOPOSIDE TONIRIBATE FORMULATION

METHOD FOR THE DIAGNOSIS OF ETOPOSIDE PRODRUG TREATABLE CANCER

ANALOGUES OF ETOPOSIDE FOR THE TREATMENT OF TUMOURS

ETOPOSIDE AND PRODRUGS THEREOF FOR USE IN TARGETING CANCER STEM CELLS

PEPTIDES CAPABLE OF MODULATING THE FUNCTION OF TIRC7

Analogues of Etoposide for the Treatment of Tumours

NOVEL TARGET IN THE TREATMENT OF CYTOKINE RELEASE SYNDROME

NOVEL TARGET IN THE TREATMENT OF CYTOKINE RELEASE SYNDROME